The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53‐Lys118 acetylation
Abstract
Myocardial infarction, an irreversible cardiac tissue damage, involves progressive loss of cardiomyocytes due to p53‐mediated apoptosis. Oxygenation is known to promote cardiac survival through activation of NOS3 gene. We hypothesized a dual role for p53, which, depending on oxygenation, can elicit apoptotic death signals or NOS3‐mediated survival signals in the infarct heart. p53 exhibited a differential DNA‐binding, namely, BAX‐p53RE in the infarct heart or NOS3‐p53RE in the oxygenated heart, which was regulated by oxygen‐induced, post‐translational modification of p53. In the infarct heart, p53 was heavily acetylated at Lys 118 residue, which was exclusively reversed in the oxygenated heart, apparently regulated by oxygen‐dependent expression of TIP60. The inhibition of Lys 118 acetylation promoted the generation of NOS3‐promoting prosurvival form of p53. Thus, oxygenation switches p53‐DNA interaction by regulating p53 core‐domain acetylation, promoting a prosurvival transcription activity of p53. Understanding this novel oxygen‐p53 survival pathway will open new avenues in cardioprotection molecular therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During periods of ischemia, reperfusion injury, and postinfarction cardiac remodeling, p53 modulates cardiomyocyte death, including autophagy, apoptosis, and necrosis.293,295,296”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [296]
In the citing paper
“p53 is significantly acetylated at the Lys (118) residue in a rat model of ischemia/reperfusion injury, which regulates p53 binding and accumulation at the Bax promoter.296”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [296]
In the citing paper
“In oxygenated MI hearts, deacetylated p53 promotes survival by binding to the promoter of the corresponding endothelial nitric oxide synthase gene.296”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [296]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 2×
“…(Xu et al, 2003). p53 phosphorylation/acetylation play crucial role in p53 half ‐ life (Kubbutat et al, 1997; Lu, 2010), nuclear localization (Kruse & Gu, 2009; Liang & Clarke, 2001), protein structure (Chehab et al, 1999; Wieczorek et al, 1996) and transcriptional activity (Brooks & Gu,…”
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“These mutants result in the lack of p53 apoptosis response (Petitjean et al, 2007).”
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
Acetylation of the p53 DNA-binding domain regulates apoptosis induction.
Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.026 · Cited by 752
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
Research works printed but not linked: 73
- Alvarado‐Vasquez N, Zapata E, Alcazar‐Leyva S, Masso F, Montano LF (2007) Reduced NO synthesis and eNOS mRNA expression in endothelial cells from newborns with a strong family history of type 2 diabetes. Diabetes Metab Res Rev 23: 559-566 · DOI
- Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8: 1243-1254 · DOI · Paper page
- Beasley R, Aldington S, Weatherall M, Robinson G, McHaffie D (2007) Oxygen therapy in myocardial infarction: an historical perspective. J R Soc Med 100: 130-133 · DOI
- Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH (2006) TIGAR, a p53‐inducible regulator of glycolysis and apoptosis. Cell 126: 107-120 · DOI · Paper page
- Bialik S, Geenen DL, Sasson IE, Cheng R, Horner JW, Evans SM, Lord EM, Koch CJ, Kitsis RN (1997) Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest 100: 1363-1372 · DOI · Paper page
- Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, et al (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378: 1847-1857 · DOI · Paper page
- Braithwaite AW, Del Sal G, Lu X (2006) Some p53‐binding proteins that can function as arbiters of life and death. Cell Death Differ 13: 984-993 · DOI
- Brooks CL, Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171 · DOI · Paper page
- Budanov AV, Shoshani T, Faerman A, Zelin E, Kamer I, Kalinski H, Gorodin S, Fishman A, Chajut A, Einat P, et al (2002) Identification of a novel stress‐responsive gene Hi95 involved in regulation of cell viability. Oncogene 21: 6017-6031 · DOI · Paper page
- Cabigas BP, Su J, Hutchins W, Shi Y, Schaefer RB, Recinos RF, Nilakantan V, Kindwall E, Niezgoda JA, Baker JE (2006) Hyperoxic and hyperbaric‐induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res 72: 143-151 · DOI
- Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942 · DOI · Paper page
- Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD (1999) Phosphorylation of Ser‐20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 96: 13777-13782 · DOI · Paper page
- Chen YK, Hsue SS, Lin LM (2003) Correlation between inducible nitric oxide synthase and p53 expression for DMBA‐induced hamster buccal‐pouch carcinomas. Oral Dis 9: 227-234 · DOI
- Chou AH, Lin AC, Hong KY, Hu SH, Chen YL, Chen JY, Wang HL (2011) p53 activation mediates polyglutamine‐expanded ataxin‐3 upregulation of Bax expression in cerebellar and pontine nuclei neurons. Neurochem Int 58: 145-152 · DOI
- Crow MT, Mani K, Nam YJ, Kitsis RN (2004) The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95: 957-970 · DOI · Paper page
- Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D, Phang JM (2001) Proline oxidase, encoded by p53‐induced gene‐6, catalyzes the generation of proline‐dependent reactive oxygen species. Cancer Res 61: 1810-1815
- Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429: 86-92 · DOI · Paper page
- Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ, Doevendans PA (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61: 414-426 · DOI · Paper page
- Fang L, Li G, Liu G, Lee SW, Aaronson SA (2001) p53 induction of heparin‐binding EGF‐like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J 20: 1931-1939 · DOI
- Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN, Ronai Z (1998) JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 12: 2658-2663 · DOI · Paper page
- Gogna R, Madan E, Keppler B, Pati U (2012a) Gallium compound GaQ(3)‐induced Ca(2 +) signalling triggers p53‐dependent and ‐independent apoptosis in cancer cells. Br J Pharmacol 166: 617-636 · DOI
- Gogna R, Madan E, Kuppusamy P, Pati U (2012b) Chaperoning of mutant p53 protein by wild‐type p53 protein causes hypoxic tumor regression. J Biol Chem 287: 2907-2914 · DOI
- Gogna R, Madan E, Kuppusamy P, Pati U (2012c) Reactive oxygen species‐mediated p53 core‐domain modifications determine apoptotic or necrotic death in cancer cells. Antioxid Redox Signal 16: 400-412 · DOI
- Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628 · DOI · Paper page
- Gu W, Roeder RG (1997) Activation of p53 sequence‐specific DNA binding by acetylation of the p53 C‐terminal domain. Cell 90: 595-606 · DOI · Paper page
- Hainaut P, Milner J (1993) Redox modulation of p53 conformation and sequence‐specific DNA binding in vitro. Cancer Res 53: 4469-4473
- Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA, Lee SW (2002) P53‐mediated induction of Cox‐2 counteracts p53‐ or genotoxic stress‐induced apoptosis. EMBO J 21: 5635-5644 · DOI · Paper page
- Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, Ichimiya M, Sengupta S, Mechanic L, Okamura S, et al (2004) p53‐induced up‐regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64: 2350-2356 · DOI · Paper page
- Janicke RU, Sohn D, Schulze‐Osthoff K (2008) The dark side of a tumor suppressor: anti‐apoptotic p53. Cell Death Differ 15: 959-976 · DOI · Paper page
- Kaeser MD, Iggo RD (2002) Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci USA 99: 95-100 · DOI · Paper page
- Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107
- Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, et al (2008) Determination of the class and isoform selectivity of small‐molecule histone deacetylase inhibitors. Biochem J 409: 581-589 · DOI · Paper page
- Khan M, Meduru S, Mohan IK, Kuppusamy ML, Wisel S, Kulkarni A, Rivera BK, Hamlin RL, Kuppusamy P (2009) Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol 47: 275-287 · DOI
- Khan M, Meduru S, Gogna R, Madan E, Citro L, Kuppusamy ML, Sayyid M, Mostafa M, Hamlin RL, Kuppusamy P (2012) Oxygen cycling in conjunction with stem cell transplantation induces NOS3 expression leading to attenuation of fibrosis and improved cardiac function. Cardiovasc Res 93: 89-99 · DOI
- Kim MY, Trudel LJ, Wogan GN (2009) Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res 29: 3733-3740
- Kimura T, Takeda S, Sagiya Y, Gotoh M, Nakamura Y, Arakawa H (2003) Impaired function of p53R2 in Rrm2b‐null mice causes severe renal failure through attenuation of dNTP pools. Nat Genet 34: 440-445 · DOI
- Ko LJ, Prives C (1996) p53: puzzle and paradigm. Genes Dev 10: 1054-1072 · DOI · Paper page
- Kones R (2011) Oxygen therapy for acute myocardial infarction‐then and now. A century of uncertainty. Am J Med 124: 1000-1005 · DOI
- Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303 · DOI · Paper page
- Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473: 326-335 · DOI · Paper page
- Le Floch R, Chiche J, Marchiq I, Naiken T, Ilk K, Murray CM, Critchlow SE, Roux D, Simon MP, Pouyssegur J (2011) CD147 subunit of lactate/H+ symporters MCT1 and hypoxia‐inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci USA 108: 16663-16668 · DOI · Paper page
- Lee SJ, Kim DC, Choi BH, Ha H, Kim KT (2006) Regulation of p53 by activated protein kinase C‐delta during nitric oxide‐induced dopaminergic cell death. J Biol Chem 281: 2215-2224 · DOI
- Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S (2003) Pirh2, a p53‐induced ubiquitin‐protein ligase, promotes p53 degradation. Cell 112: 779-791 · DOI · Paper page
- Levine AJ, Hu W, Feng Z (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036 · DOI · Paper page
- Liang SH, Clarke MF (2001) Regulation of p53 localization. Eur J Biochem 268: 2779-2783 · DOI · Paper page
- Lu X (2010) Tied up in loops: positive and negative autoregulation of p53. Cold Spring Harb Perspect Biol 2: a000984
- Madan E, Gogna R, Bhatt M, Pati U, Kuppusamy P, Mahdi AA (2011) Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget 2: 948-957 · DOI
- Madan E, Gogna R, Kuppusamy P, Bhatt M, Pati U, Mahdi AA (2012) TIGAR induces p53‐mediated cell‐cycle arrest by regulation of RB–E2F1 complex. Br J Cancer 107: 516-526 · DOI
- Masutani H, Ueda S, Yodoi J (2005) The thioredoxin system in retroviral infection and apoptosis. Cell Death Differ 12: 991-998 · DOI
- Mellert H, Sykes SM, Murphy ME, McMahon SB (2007) The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain. Cell Cycle 6: 1304-1306 · DOI
- Monte M, Benetti R, Buscemi G, Sandy P, Del Sal G, Schneider C (2003) The cell cycle‐regulated protein human GTSE‐1 controls DNA damage‐induced apoptosis by affecting p53 function. J Biol Chem 278: 30356-30364 · DOI
- Oerlemans MI, Koudstaal S, Chamuleau SA, de Kleijn DP, Doevendans PA, Sluijter JP (2012) Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol 165: 410-422 · DOI
- Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, Lee SW (2003) p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J 22: 1289-1301 · DOI · Paper page
- Ripa RS, Wang Y, Jorgensen E, Johnsen HE, Hesse B, Kastrup J (2006) Intramyocardial injection of vascular endothelial growth factor‐A165 plasmid followed by granulocyte‐colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur Heart J 27: 1785-1792 · DOI
- Rowland BD, Bernards R, Peeper DS (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context‐dependent oncogene. Nat Cell Biol 7: 1074-1082 · DOI · Paper page
- Ryan JL (2012) Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol 132: 985-993 · DOI · Paper page
- Tan M, Li S, Swaroop M, Guan K, Oberley LW, Sun Y (1999) Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274: 12061-12066 · DOI · Paper page
- Tang Y, Luo J, Zhang W, Gu W (2006) Tip60‐dependent acetylation of p53 modulates the decision between cell‐cycle arrest and apoptosis. Mol Cell 24: 827-839 · DOI · Paper page
- Utrera R, Collavin L, Lazarevic D, Delia D, Schneider C (1998) A novel p53‐inducible gene coding for a microtubule‐localized protein with G2‐phase‐specific expression. EMBO J 17: 5015-5025 · DOI
- Velasco‐Miguel S, Buckbinder L, Jean P, Gelbert L, Talbott R, Laidlaw J, Seizinger B, Kley N (1999) PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18: 127-137 · DOI · Paper page
- Vousden KH (2006) Outcomes of p53 activation—spoilt for choice. J Cell Sci 119: 5015-5020 · DOI · Paper page
- Wieczorek AM, Waterman JL, Waterman MJ, Halazonetis TD (1996) Structure‐based rescue of common tumor‐derived p53 mutants. Nat Med 2: 1143-1146 · DOI
- Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R (2009) Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart 95: 198-202 · DOI · Paper page
- Wu WS, Heinrichs S, Xu D, Garrison SP, Zambetti GP, Adams JM, Look AT (2005) Slug antagonizes p53‐mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 123: 641-653 · DOI · Paper page
- Xu JM, Tan R, Hu DX (2003) Effect of ischemic preconditioning on myocardial bcl‐2, bax, p53 gene expression during ischemia/reperfusion period in rabbits. Hunan Yi Ke Da Xue Xue Bao 28: 111-113
- Yan W, Chen X (2006) GPX2, a direct target of p63, inhibits oxidative stress‐induced apoptosis in a p53‐dependent manner. J Biol Chem 281: 7856-7862 · DOI · Paper page
- Yang XJ, Seto E (2008) The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 9: 206-218 · DOI · Paper page
- Yaoita H, Ogawa K, Maehara K, Maruyama Y (2000) Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction. Cardiovasc Res 45: 630-641 · DOI · Paper page
- Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S (2008) Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide? J Surg Res 149: 155-164 · DOI
- Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S (2010) Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovasc Revasc Med 11: 8-19 · DOI
- Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS, Yang VW (2000) The gut‐enriched Kruppel‐like factor (Kruppel‐like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275: 18391-18398 · DOI · Paper page
- Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten‐Johansen J (2000) Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45: 651-660 · DOI · Paper page
- Zheng J, Fang J, Yin YJ, Wang XC, Ren AJ, Bai J, Sun XJ, Yuan WJ, Lin L (2010) Leptin protects cardiomyocytes from serum‐deprivation‐induced apoptosis by increasing anti‐oxidant defence. Clin Exp Pharmacol Physiol 37: 955-962 · DOI
Cited by
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 373
The complexity of p53-mediated metabolic regulation in tumor suppression
Liu, Y., & Gu, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.010 · Cited by 261
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Metadata
- Authors
- Gogna, R., Madan, E., Khan, M., Pati, U., & Kuppusamy, P.
- Venue
- EMBO Molecular Medicine
- Published
- 2013-10-01
- Volume
- 5
- Issue
- 11
- Pages
- 1662-1683
- ISSN
- 1757-4676
- 1757-4684
- Cited by
- 29
- References
- 5
- Language
- en
- Licence
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53‐Lys118 acetylation. https://app.cochat.ai/papers/10.1002/emmm.201202055
- The paper
- Gogna, R., Madan, E., Khan, M., Pati, U., & Kuppusamy, P. (2013). p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53‐Lys118 acetylation. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201202055
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.